Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.50392 | 20 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.47647 | 20 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.47522 | 20 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.41474 | 19 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.41672 | 19 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.54187 | 20 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.50417 | 20 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.45874 | 20 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.4464 | 20 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.46598 | 20 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.46292 | 20 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.45909 | 20 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.47108 | 20 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.46721 | 20 |